Optimization of a murine immunization model for study of PF4/heparin antibodies. - Wikidata - wikimedia - TriplyDB

Optimization of a murine immunization model for study of PF4/heparin antibodies.

Optimization of a murine immunization model for study of PF4/heparin antibodies.

http://www.wikidata.org/entity/Q33383456

about

Endothelial antigen assembly leads to thrombotic complications in heparin-induced thrombocytopenia Heparin modifies the immunogenicity of positively charged proteins.Disruption of PF4/H multimolecular complex formation with a minimally anticoagulant heparin (ODSH)Critical role for mouse marginal zone B cells in PF4/heparin antibody production.Emphasis on the Role of PF4 in the Incidence, Pathophysiology and Treatment of Heparin Induced Thrombocytopenia.Complex formation with nucleic acids and aptamers alters the antigenic properties of platelet factor 4.Advances in the pathophysiology and treatment of heparin-induced thrombocytopenia.Evaluation of Immunostimulatory Potential of Branded and US-Generic Enoxaparins in an In Vitro Human Immune System Model.

P2860

Q30840169-86D911C3-3729-4667-9952-0BE330D2F3D1 Q33391937-5612CB12-5782-4D68-8C5A-37A42A60B1BB Q33399613-180ECB0C-51E4-46D0-AE60-9EC883A7B9C1 Q33406245-4BE2D2A6-421A-4F4F-8984-E0332311F2E2 Q33406904-AC7ABCC9-DBAD-4699-9723-E7C0C27D4561 Q33407740-5DAAE78E-1515-4EE4-A92D-E6846B36D16F Q33416269-7F7A113E-ECA3-480D-A609-9970931F7589 Q35465768-E500A407-68DB-4152-ACC9-9DA6B0170D70

P2860

Optimization of a murine immunization model for study of PF4/heparin antibodies.

http://www.wikidata.org/entity/Q33383456

description

2009 nî lūn-bûn

@nan

2009 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Optimization of a murine immunization model for study of PF4/heparin antibodies.

@ast

Optimization of a murine immunization model for study of PF4/heparin antibodies.

@en

type

label

Optimization of a murine immunization model for study of PF4/heparin antibodies.

@ast

Optimization of a murine immunization model for study of PF4/heparin antibodies.

@en

prefLabel

Optimization of a murine immunization model for study of PF4/heparin antibodies.

@ast

Optimization of a murine immunization model for study of PF4/heparin antibodies.

@en

P1433

Q33383456-272A81B0-D8F8-4682-AA76-120D93929865

P1476

Q33383456-1B92372C-1D6D-4BA6-A7C2-FFE963001A77

P2093

Q33383456-05D481C8-E344-45BE-8BEC-9368B3A0E395

Q33383456-8195DCA3-AB6C-4FB9-BD9D-D59F58A08C59

Q33383456-CB4F285A-79ED-4DE5-BC92-7B7D810A3404

P2860

Q33383456-002D61D8-4FED-4F21-8BDB-9F3999E63B75

Q33383456-01E0DB60-A6C5-44FD-A7D0-A47B763E209C

Q33383456-07486723-147D-4D1C-ABB1-13683BDB6308

Q33383456-08B09EFC-98D7-4866-A2B1-9AC1E9C92CB6

Q33383456-299AAE34-3DEE-4EE7-9180-52960916C1C6

Q33383456-3060C90D-6015-4B2A-8CD8-961328A58131

Q33383456-448C0F3F-05EB-43CD-A1B3-6580F2A87DC4

Q33383456-532BF12A-D1A5-4BF1-A88C-17FE5E56591F

Q33383456-583A7B17-8992-4C53-80C0-3AF6F9AB220C

Q33383456-595DEB62-39B7-43BB-AD6B-C1E2FCF033C5

P304

Q33383456-F6839EC5-17B8-433E-85B1-32CC5A990C6D

P31

Q33383456-E61DF9D8-E3AB-4CFB-8639-A327D9C642C2

P356

Q33383456-C57ED2FD-9C90-4206-9CF3-2C0FFD948472

P433

Q33383456-8970331E-4951-4620-B73F-8EA5B6CA184F

P478

Q33383456-F0B369B7-3E68-425E-9489-6ECDBA7412E6

P577

Q33383456-689CC418-1D7D-429D-BA8D-4BBBD2591A3B

P5875

Q33383456-57E0F2B7-9B6A-42FC-B489-3BC0051D52EB

P698

Q33383456-07097860-D8D5-4563-9B9E-1FB0EA071996

P932

Q33383456-99F3F50E-247E-4D8A-88C1-B86DC9EE35C4

P356

J.1538-7836.2009.03330.X

P1433

Journal of Thrombosis and Haemostasis

P1476

Optimization of a murine immunization model for study of PF4/heparin antibodies.

@en

P2093

G M Arepally

http://www.w3.org/2001/XMLSchema#string

R Qi

http://www.w3.org/2001/XMLSchema#string

S Suvarna

http://www.w3.org/2001/XMLSchema#string

P2860

The anamnestic neutralizing antibody response is critical for protection of mice from challenge following vaccination with a plasmid encoding the Japanese encephalitis virus premembrane and envelope genes.

Impact of the patient population on the risk for heparin-induced thrombocytopenia.

Temporal aspects of heparin-induced thrombocytopenia.

Heparin-induced thrombocytopenia/thrombosis in a transgenic mouse model requires human platelet factor 4 and platelet activation through FcgammaRIIA.

Defining a second epitope for heparin-induced thrombocytopenia/thrombosis antibodies using KKO, a murine HIT-like monoclonal antibody.

Ultralarge complexes of PF4 and heparin are central to the pathogenesis of heparin-induced thrombocytopenia.

PF4/heparin complexes are T cell-dependent antigens.

Risk for heparin-induced thrombocytopenia with unfractionated and low-molecular-weight heparin thromboprophylaxis: a meta-analysis.

Clinical features of heparin-induced thrombocytopenia including risk factors for thrombosis. A retrospective analysis of 408 patients.

Close approximation of two platelet factor 4 tetramers by charge neutralization forms the antigens recognized by HIT antibodies.

P304

857-864

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1538-7836.2009.03330.X

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P577

2009-02-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

24042695

http://www.w3.org/2001/XMLSchema#string

P698

19245419

http://www.w3.org/2001/XMLSchema#string

P932

3711941

http://www.w3.org/2001/XMLSchema#string